Sanofi values Genzyme at low $70's, plus CVR

PHILADELPHIA/BOSTON (Reuters) - France's Sanofi-Aventis has agreed to raise its bid for Genzyme Corp to the low $70's per share range, plus a milestone payment based on the performance of an...